Olaparib and Radiotherapy in Head and Neck Cancer

NCT02229656 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Laryngeal Cancer Stage II
Laryngeal Cancer Stage III
Carcinoma, Squamous Cell
Head and Neck Neoplasms

Interventions

RADIATION: radiotherapy
DRUG: Olaparib

Sponsor

The Netherlands Cancer Institute

Collaborators

[object Object]